E. Ohman J:or Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

E. Ohman J:or Asset Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22,152	Closed	-$1.17M	–	480
2026 Q1	$1.17M	Buy	22,152 +950	+4%	+$39K	0.03%	258
2025 Q4	$857K	Sell	21,202 -81,208	-79%	-$1.88M	0.02%	324
2025 Q3	$769K	Hold	102,410	–	–	0.02%	309
2025 Q2	$382K	Hold	102,410	–	–	0.01%	390
2025 Q1	$283K	Buy	102,410 +22,032	+27%	+$90K	0.01%	408
2024 Q4	$445K	Buy	80,378 +18,603	+30%	+$126K	0.01%	390
2024 Q3	$515K	Buy	+61,775	New	+$508K	0.01%	358

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

E. Ohman J:or Asset Management's TERN Position: Q2 2026 in Review

E. Ohman J:or Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 22,152 shares — an estimated $1.17M sold.

E. Ohman J:or Asset Management first reported a position in TERN in Q3 2024 and held it in 7 quarters. The position peaked at $1.17M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

E. Ohman J:or Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
E. Ohman J:or Asset Management sold 22,152 Terns Pharmaceuticals shares in Q2 2026, an estimated $1.17M.
E. Ohman J:or Asset Management first reported a position in Terns Pharmaceuticals in Q3 2024 and held it in 7 quarters.
E. Ohman J:or Asset Management's Terns Pharmaceuticals position peaked at $1.17M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.